Anti-Reflux Mucosectomy Effective for GERD in Long Term
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, June 29, 2023 -- For patients with gastroesophageal reflux disease (GERD), anti-reflux mucosectomy (ARMS) shows long-term efficacy and is also effective for patients with reflux hypersensitivity, according to a study published online June 18 in Digestive Endoscopy.
Kazuya Sumi, M.D., from Showa University Koto-Toyosu Hospital in Tokyo, and colleagues conducted a single-center, single-arm prospective study of 88 patients with proton pump inhibitor (PPI)-refractory GERD who underwent ARMS from June 2012 to June 2017; 60 patients were followed for more than five years or received additional treatment. The rates of long-term effectiveness and PPI discontinuation were examined as the primary outcomes.
The researchers found that ARMS yielded a long-term effect in 68.3 percent of patients, and 42 percent could discontinue PPIs. Significant differences were seen in age, intensity of preoperative symptoms, and acid-related indicators. ARMS provided long-term effectiveness in 81 percent of the 27 patients with reflux hypersensitivity. Those with short- and long-term efficacy had no significant difference in subjective symptom assessment. In 23 percent of patients, additional treatment was administered, scheduled at the one- to two-year follow-up.
"ARMS is a simple endoscopic procedure that could reduce treatment costs (i.e., by weaning from PPIs) and avoid to use foreign objects," the authors write. "In addition, ARMS has the potential to bridge the gap between medical and surgical treatment, and to be effective in the long term for patients with pure GERD and reflux hypersensitivity."
One author disclosed ties to the pharmaceutical and medical device industries.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Use of Acid-Suppression Therapy Linked to Migraine, Severe Headache
FRIDAY, April 26, 2024 -- Use of acid-suppression therapy is associated with higher odds of migraine or severe headache, according to a study published online April 24 in...
Anxiety, Depression Associated With Gastroesophageal Reflux Disease
TUESDAY, April 2, 2024 -- Anxiety and depression are associated with an increased incidence of gastroesophageal reflux disease (GERD), according to a study published online March...
Validated COuGH RefleX Score Can Predict Likelihood of GERD
WEDNESDAY, March 6, 2024 -- The validated Cough, Overweight/Obesity, Globus, Hiatal Hernia, Regurgitation, and Male Sex (COuGH RefluX) score can predict the likelihood of proven...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.